Booming VC-Backed Biopharma: Strong Market Despite Pandemic

Biopharma Venture Capital funding hit all-time-highs during the first quarter of 2020. Author shares the data and reflects on the market in light of COVID.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive